BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 15041532)

  • 1. Effect of inhibition of EBV-encoded latent membrane protein-1 by small interfering RNA on EBV-positive nasopharyngeal carcinoma cell growth.
    Li G; Li XP; Peng Y; Liu X; Li XH
    Di Yi Jun Yi Da Xue Xue Bao; 2004 Mar; 24(3):241-6. PubMed ID: 15041532
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epstein-Barr virus (EBV) latent membrane protein 1 induces interleukin-8 through the nuclear factor-kappa B signaling pathway in EBV-infected nasopharyngeal carcinoma cell line.
    Ren Q; Sato H; Murono S; Furukawa M; Yoshizaki T
    Laryngoscope; 2004 May; 114(5):855-9. PubMed ID: 15126743
    [TBL] [Abstract][Full Text] [Related]  

  • 3. siRNA targeting LMP1-induced apoptosis in EBV-positive lymphoma cells is associated with inhibition of telomerase activity and expression.
    Mei YP; Zhu XF; Zhou JM; Huang H; Deng R; Zeng YX
    Cancer Lett; 2006 Feb; 232(2):189-98. PubMed ID: 16458115
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effective inhibition of EB virus-encoded latent membrane protein-1 by siRNA in EB virus (+) nasopharyngeal carcinoma cell].
    Li G; Li XP; Peng Y; Liu X; Li XH
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2005 Jun; 40(6):406-10. PubMed ID: 16145771
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effects of two LMP1 variants on resistance of CNE1 cell strain to TGF-beta1].
    Huang H; Huang PC
    Ai Zheng; 2003 Dec; 22(12):1254-9. PubMed ID: 14693046
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DNAzymes targeted to EBV-encoded latent membrane protein-1 induce apoptosis and enhance radiosensitivity in nasopharyngeal carcinoma.
    Lu ZX; Ma XQ; Yang LF; Wang ZL; Zeng L; Li ZJ; Li XN; Tang M; Yi W; Gong JP; Sun LQ; Cao Y
    Cancer Lett; 2008 Jul; 265(2):226-38. PubMed ID: 18353539
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effect of rAAV-mediated RNA interference against EB virus-encoded latent membrane protein 1 on nasopharyngeal carcinoma cell proliferation and metastasis in nude mice].
    Liu X; Liu X; Li G; Zhang B; Wang L; Li XH; Li XP
    Nan Fang Yi Ke Da Xue Xue Bao; 2009 Apr; 29(4):611-4. PubMed ID: 19403376
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epstein-Barr virus infection in precursor lesions of nasopharyngeal carcinoma.
    Zhong BL; Zong YS; Lin SX; Zhang M; Liang YJ
    Ai Zheng; 2006 Feb; 25(2):136-42. PubMed ID: 16480574
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recombinant adeno-associated virus mediated RNA interference inhibits metastasis of nasopharyngeal cancer cells in vivo and in vitro by suppression of Epstein-Barr virus encoded LMP-1.
    Li X; Liu X; Li CY; Ding Y; Chau D; Li G; Kung HF; Lin MC; Peng Y
    Int J Oncol; 2006 Sep; 29(3):595-603. PubMed ID: 16865275
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of matrix metalloproteinases by Epstein-Barr virus latent membrane protein 1 isolated from nasopharyngeal carcinoma.
    Lee DC; Chua DT; Wei WI; Sham JS; Lau AS
    Biomed Pharmacother; 2007 Oct; 61(9):520-6. PubMed ID: 17913445
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Inhibition of EBV-encoded LMP-1 by DNA-based RNA interference affects metastatic ability of nasopharyngeal carcinoma cells].
    Li G; Li XP; Liu X; Peng Y; Lin MC
    Zhonghua Zhong Liu Za Zhi; 2006 Oct; 28(10):724-7. PubMed ID: 17366780
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epstein-Barr virus latent membrane protein 1 (EBV-LMP1) and tumor proliferation rate as predictive factors of nasopharyngeal cancer (NPC) radiation response.
    Gondhowiardjo S
    Gan To Kagaku Ryoho; 2000 May; 27 Suppl 2():323-31. PubMed ID: 10895175
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Latent membrane protein-1 of Epstein - Barr virus increases sensitivity to arsenic trioxide-induced apoptosis in nasopharyngeal carcinoma cell.
    Du CW; Wen BG; Li DR; Lin YC; Zheng YW; Chen L; Chen JY; Lin W; Wu MY
    Exp Oncol; 2005 Dec; 27(4):267-72. PubMed ID: 16404345
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of EB virus latent membrane protein 1 on mitosis control of nasopharyngeal carcinoma cell line CNE1].
    Liu B; Chen XY
    Ai Zheng; 2004 May; 23(5):512-6. PubMed ID: 15142445
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epstein-Barr virus (EBV) latent membrane protein-1-specific cytotoxic T lymphocytes targeting EBV-carrying natural killer cell malignancies.
    Demachi-Okamura A; Ito Y; Akatsuka Y; Tsujimura K; Morishima Y; Takahashi T; Kuzushima K
    Eur J Immunol; 2006 Mar; 36(3):593-602. PubMed ID: 16479544
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effects of Epstein-Barr virus latent membrane protein 1(EBV-LMP1) on related factors of metastasis of nasopharyngeal carcinoma cell line CNE1].
    Gou XM; Chen Y; Chen XY; Arrand JR
    Ai Zheng; 2003 May; 22(5):481-5. PubMed ID: 12753707
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effects of Epstein-Barr virus latent membrane protein 1 on metastasis of human nasopharyngeal carcinoma cell lines].
    Ou XB; Chen XY; Wu MH; Luo WR
    Ai Zheng; 2008 Aug; 27(8):803-8. PubMed ID: 18710612
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exosomes released by EBV-infected nasopharyngeal carcinoma cells convey the viral latent membrane protein 1 and the immunomodulatory protein galectin 9.
    Keryer-Bibens C; Pioche-Durieu C; Villemant C; Souquère S; Nishi N; Hirashima M; Middeldorp J; Busson P
    BMC Cancer; 2006 Dec; 6():283. PubMed ID: 17156439
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cooperative interactions among p53, bcl-2 and Epstein-Barr virus latent membrane protein 1 in nasopharyngeal carcinoma cells.
    Sheu LF; Chen A; Lee HS; Hsu HY; Yu DS
    Pathol Int; 2004 Jul; 54(7):475-85. PubMed ID: 15189500
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epstein-Barr virus LMP1 status in relation to apoptosis, p53 expression and leucocyte infiltration in nasopharyngeal carcinoma.
    Shao JY; Ernberg I; Biberfeld P; Heiden T; Zeng YX; Hu LF
    Anticancer Res; 2004; 24(4):2309-18. PubMed ID: 15330177
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.